Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Cancer|March 1, 1991
Fibrin formation on vessel walls in hyperplastic and malignant prostate tissueM Z Wojtukiewicz, L R Zacharski, V A Memoli, et al.
Journal of the American College of Cardiology|March 1, 1993
Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy. The TAMI Study GroupT C Wall, R M Califf, S G Ellis, et al.
The American Journal of Cardiology|April 1, 1988
Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarctionE J Topol, B S George, D J Kereiakes, et al.
American Heart Journal|January 3, 2001
Determination of a weight-adjusted dose of TNK-tissue plasminogen activatorF Wang-Clow, N L Fox, C P Cannon, et al.
Annals of Internal Medicine|August 15, 1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II TrialE G Bovill, M L Terrin, D C Stump, et al.
Circulation|May 1, 1988
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarctionE J Topol, R M Califf, B S George, et al.
Circulation|February 1, 1989
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarctionE J Topol, B S George, D J Kereiakes, et al.
Thrombosis and Haemostasis|March 4, 1991
Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarctionD C Sane, D C Stump, E J Topol, et al.
Journal of the American College of Cardiology|October 1, 1989
Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study GroupE J Topol, S G Ellis, R M Califf, et al.
Circulation|January 1, 1991
Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study GroupD C Sane, D C Stump, E J Topol, et al.
Pageof 7